Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04764292 · ClinicalTrials.gov registry record · Phase 4
Screening Contrast-Enhanced Mammography as an Alternative to MRI
A Phase 4 study, sponsored by Wendie Berg.
- Completed
- Registry status
- Phase 4
- Development phase
- 615
- Enrollment target
NCT04764292 is a Phase 4 study that has completed, run by Wendie Berg. The registered enrollment target is 615 participants.
The verdict
NCT04764292, a Phase 4 study, has completed, sponsored by Wendie Berg.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 615 participants
- Enrollment target
Study Summary
There are women for whom a screening breast MRI is clinically recommended, but not feasible either due to patient factors (body habitus, pacemaker or other implant, claustrophobia) or access (cost, other constraints). Contrast-enhanced mammography (CEM) is a potential alternative to MRI for screening that uses updated standard mammography equipment to obtain low- and high-energy images after intravenous injection of iodinated contrast (as used in CT scanning). The investigators seek to validate screening CEM as an alternative to screening MRI.
Interventions
- DRUG Iodinated Contrast Media (ICM)
- DEVICE Contrast-enhanced mammography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 615 participants |
| Start Date | 2021-02-15 |
| Est. Completion | 2025-05-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04764292
The ClinicalTrials.gov registry entry for NCT04764292 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 615 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wendie Berg, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Iodinated Contrast Media (ICM) is the first listed.
NCT04764292 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04764292 about?
NCT04764292 is a clinical study titled "Screening Contrast-Enhanced Mammography as an Alternative to MRI". There are women for whom a screening breast MRI is clinically recommended, but not feasible either due to patient factors (body habitus, pacemaker or other implant, claustrophobia) or access (cost, other constraints). Contrast-enhanced mammography (CEM) is a potential alternative to MRI for screenin...
What is the current status of trial NCT04764292?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 615 participants. The study started on 2021-02-15. Estimated completion is 2025-05-30.
What interventions are being tested in trial NCT04764292?
The interventions under investigation include: Iodinated Contrast Media (ICM) (DRUG), Contrast-enhanced mammography (DEVICE).
Who is sponsoring clinical trial NCT04764292?
This trial is sponsored by Wendie Berg, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.